Master in Pharmacovigilance: A Training Programme to Improve the Quality of a Drug Surveillance System

被引：0
|
作者：
M. Di Pirro
M. Moschini
F. Lapi
M. Vietri
E. Cecchi
G. Banchelli
E. Gallo
A. Fazzini
A. Mugelli
A. Vannacci
机构：
[1] Department of Preclinical and Clinical Pharmacology,
来源：
Drug Safety | 2008年 / 31卷
关键词：
Master Program; Local Health Department; Pharmacovigilance System; Master Duration; Train Health Professional;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：885 / 885
相关论文
共 50 条
  • [1] Master in Pharmacovigilance: A Training Programme to Improve the Quality of a Drug Surveillance System
    Di Pirro, M.
    Moschini, M.
    Lapi, F.
    Vietri, M.
    Cecchi, E.
    Banchelli, G.
    Gallo, E.
    Fazzini, A.
    Mugelli, A.
    Vannacci, A.
    [J]. DRUG SAFETY, 2008, 31 (10) : 911 - 911
  • [2] Training On the Master Programme in England
    Braun, Eva
    [J]. FLEISCHWIRTSCHAFT, 2013, 93 (03): : 83 - 85
  • [3] Pharmacovigilance of Drug Quality Deviation in the Public Health System
    Menezes de Padua, Cristiane A.
    Bitencourt, Carolina R.
    Perini, Edson
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 609 - 610
  • [4] Strengthening the Bolivian pharmacovigilance system: New surveillance strategies to improve care for Chagas disease and tuberculosis
    Cortes-Serra, Nuria
    Saravia, Ruth
    Mary Grageda, Rosse
    Apaza, Amilcar
    Armando Gonzalez, Jorge
    Rios, Brenda
    Gascon, Joaquim
    Torrico, Faustino
    Pinazo, Maria-Jesus
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2020, 14 (09): : 1 - 12
  • [5] Pharmacovigilance and Patients: How to Improve Reports' Quality?
    Le Louet, A. Lillo
    Barillier, H.
    Le Bellet, C.
    Le Louet, H.
    [J]. DRUG SAFETY, 2017, 40 (10) : 1012 - 1012
  • [6] Adverse drug reactions reporting culture in Pharmacovigilance Programme of India
    Kalaiselvan, Vivekanandan
    Prasad, Thota
    Bisht, Akanksha
    Singh, Surinder
    Singh, Gyanendra Nath
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2014, 140 : 563 - 564
  • [7] Managing Data Quality for a Drug Safety Surveillance System
    Abraham G. Hartzema
    Christian G. Reich
    Patrick B. Ryan
    Paul E. Stang
    David Madigan
    Emily Welebob
    J. Marc Overhage
    [J]. Drug Safety, 2013, 36 : 49 - 58
  • [8] Managing Data Quality for a Drug Safety Surveillance System
    Hartzema, Abraham G.
    Reich, Christian G.
    Ryan, Patrick B.
    Stang, Paul E.
    Madigan, David
    Welebob, Emily
    Overhage, J. Marc
    [J]. DRUG SAFETY, 2013, 36 : S49 - S58
  • [9] Findings from a UK-Morocco training programme to improve capacity in nutrition surveillance, research and education
    Mocciaro, G.
    Ziauddeen, N.
    Nicholson, S.
    Almoosawi, S.
    Ray, S.
    [J]. PUBLIC HEALTH, 2017, 142 : 208 - 211
  • [10] Pharmacovigilance off the beaten track: Drug surveillance of herbal medicines
    Castot, A
    Djezzar, S
    Deleau, N
    Guillot, B
    Efthymiou, ML
    [J]. THERAPIE, 1997, 52 (02): : 97 - 103
12345